In an analysis of 55 trials evaluating tamoxifen versus placebo in the adjuvant treatment of breast cancer, 5 years of tamoxifen therapy resulted in a 47 reduction in recurrence and a 22 reduction in mortality <a href=http://clomid.mom/>clomiphene citrate</a> Nilotinib UGT1A1 28 28 poor metabolizers Results in higher adverse reaction risk hyperbilirubinemia